Kaleido Biosciences (KLDO) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends KLDO vs. SYBX, CXAI, HKIT, ABTS, HOLO, GVP, GIGM, MNDR, MMV, and CNETShould you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include Synlogic (SYBX), CXApp (CXAI), Hitek Global (HKIT), Abits Group (ABTS), MicroCloud Hologram (HOLO), GSE Systems (GVP), GigaMedia (GIGM), Mobile-health Network Solutions (MNDR), MultiMetaVerse (MMV), and ZW Data Action Technologies (CNET). Kaleido Biosciences vs. Synlogic CXApp Hitek Global Abits Group MicroCloud Hologram GSE Systems GigaMedia Mobile-health Network Solutions MultiMetaVerse ZW Data Action Technologies Kaleido Biosciences (NASDAQ:KLDO) and Synlogic (NASDAQ:SYBX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, community ranking, dividends and analyst recommendations. Is KLDO or SYBX more profitable? Kaleido Biosciences has a net margin of 0.00% compared to Synlogic's net margin of -2,284.65%. Kaleido Biosciences' return on equity of 0.00% beat Synlogic's return on equity.Company Net Margins Return on Equity Return on Assets Kaleido BiosciencesN/A N/A N/A Synlogic -2,284.65%-194.73%-112.61% Which has more volatility and risk, KLDO or SYBX? Kaleido Biosciences has a beta of -0.06, meaning that its share price is 106% less volatile than the S&P 500. Comparatively, Synlogic has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Do insiders & institutionals have more ownership in KLDO or SYBX? 81.6% of Kaleido Biosciences shares are held by institutional investors. Comparatively, 63.4% of Synlogic shares are held by institutional investors. 9.0% of Kaleido Biosciences shares are held by insiders. Comparatively, 8.0% of Synlogic shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts prefer KLDO or SYBX? Synlogic has a consensus target price of $30.00, suggesting a potential upside of 1,997.90%. Given Synlogic's higher possible upside, analysts clearly believe Synlogic is more favorable than Kaleido Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kaleido Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ASynlogic 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 Which has higher earnings and valuation, KLDO or SYBX? Synlogic has higher revenue and earnings than Kaleido Biosciences. Synlogic is trading at a lower price-to-earnings ratio than Kaleido Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKaleido Biosciences$1.10M0.00-$95.48M-$2.24N/ASynlogic$3.37M4.96-$57.28M-$6.72-0.21 Does the MarketBeat Community believe in KLDO or SYBX? Synlogic received 277 more outperform votes than Kaleido Biosciences when rated by MarketBeat users. Likewise, 69.54% of users gave Synlogic an outperform vote while only 57.45% of users gave Kaleido Biosciences an outperform vote. CompanyUnderperformOutperformKaleido BiosciencesOutperform Votes5457.45% Underperform Votes4042.55% SynlogicOutperform Votes33169.54% Underperform Votes14530.46% Does the media favor KLDO or SYBX? In the previous week, Synlogic had 2 more articles in the media than Kaleido Biosciences. MarketBeat recorded 2 mentions for Synlogic and 0 mentions for Kaleido Biosciences. Kaleido Biosciences' average media sentiment score of 0.00 beat Synlogic's score of -0.50 indicating that Kaleido Biosciences is being referred to more favorably in the media. Company Overall Sentiment Kaleido Biosciences Neutral Synlogic Negative SummaryKaleido Biosciences and Synlogic tied by winning 8 of the 16 factors compared between the two stocks. Ad Crypto 101 MediaThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.Click here to discover our #1 crypto for the market right now – poised for massive growth Get Kaleido Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLDO vs. The Competition Export to ExcelMetricKaleido BiosciencesBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$4,000.00$202.91M$5.02B$8.42BDividend YieldN/A3.48%7.52%4.16%P/E Ratio0.00337.76128.8716.66Price / SalesN/A21,765.411,725.1179.42Price / CashN/A11.0836.9133.53Price / BookN/A6.874.595.19Net Income-$95.48M-$19.89M$114.09M$223.67M Kaleido Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLDOKaleido BiosciencesN/AN/AN/AN/A$4,000.00$1.10M0.0076SYBXSynlogic2.7534 of 5 stars$1.46flat$30.00+1,954.8%-21.5%$17.09M$3.17M-0.2280Positive NewsCXAICXApp0.3428 of 5 stars$1.45-3.3%N/A-10.8%$22.12M$-2,446,000.000.002HKITHitek Global1.0451 of 5 stars$1.41-1.4%N/A+3.0%$20.22M$4.56M0.0075Gap DownABTSAbits Group0.0846 of 5 stars$0.55-5.1%N/AN/A$19.68M$5.34M0.0011Gap UpHOLOMicroCloud Hologram0.1885 of 5 stars$2.85-14.7%N/A-97.7%$16.93M$234.30M0.002Gap DownHigh Trading VolumeGVPGSE Systems1.9317 of 5 stars$4.60+0.2%$13.00+182.6%N/A$15.97M$44.79M-1.82252High Trading VolumeGIGMGigaMedia0.8079 of 5 stars$1.41+1.4%N/A+4.1%$15.53M$3.39M-3.7096Analyst ForecastMNDRMobile-health Network SolutionsN/A$0.46-6.1%N/AN/A$14.61M$13.97M0.00N/AGap DownMMVMultiMetaVerseN/A$0.44-2.2%N/A-75.7%$14.52M$9.01M0.0081Gap UpCNETZW Data Action Technologies1.0115 of 5 stars$1.95-11.8%N/A-57.9%$14.05M$24.40M-0.7950Analyst ForecastNews CoverageGap Down Related Companies and Tools Related Companies Synlogic Competitors CXApp Competitors Hitek Global Competitors Abits Group Competitors MicroCloud Hologram Competitors GSE Systems Competitors GigaMedia Competitors Mobile-health Network Solutions Competitors MultiMetaVerse Competitors ZW Data Action Technologies Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KLDO) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kaleido Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kaleido Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
